Use of Statins and the Risk of Death in Patients With Prostate Cancer
Top Cited Papers
- 1 January 2014
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (1), 5-11
- https://doi.org/10.1200/jco.2013.49.4757
Abstract
To determine whether the use of statins after prostate cancer diagnosis is associated with a decreased risk of cancer-related mortality and all-cause mortality and to assess whether this association is modified by prediagnostic use of statins. A cohort of 11,772 men newly diagnosed with nonmetastatic prostate cancer between April 1, 1998, and December 31, 2009, followed until October 1, 2012, was identified using a large population-based electronic database from the United Kingdom. Time-dependent Cox proportional hazards models were used to estimate adjusted hazard ratios (HRs) with 95% CIs of mortality outcomes associated with postdiagnostic use of statins, lagged by 1 year to account for latency considerations and to minimize reverse causality, and considering effect modification by prediagnostic use of statins. During a mean follow-up time of 4.4 years (standard deviation, 2.9 years), 3,499 deaths occurred, including 1,791 from prostate cancer. Postdiagnostic use of statins was associated with a decreased risk of prostate cancer mortality (HR, 0.76; 95% CI, 0.66 to 0.88) and all-cause mortality (HR, 0.86; 95% CI, 0.78 to 0.95). These decreased risks of prostate cancer mortality and all-cause mortality were more pronounced in patients who also used statins before diagnosis (HR, 0.55; 95% CI, 0.41 to 0.74; and HR, 0.66; 95% CI, 0.53 to 0.81, respectively), with weaker effects in patients who initiated the treatment only after diagnosis (HR, 0.82; 95% CI, 0.71 to 0.96; and HR, 0.91; 95% CI, 0.82 to 1.01, respectively). Overall, the use of statins after diagnosis was associated with a decreased risk in prostate cancer mortality. However, this effect was stronger in patients who also used statins before diagnosis.This publication has 23 references indexed in Scilit:
- Statin Use in Relation to Prostate Cancer Outcomes in a Population-based Patient Cohort StudyThe Prostate, 2013
- Statin Use and Reduced Cancer-Related MortalityThe New England Journal of Medicine, 2012
- Improved Biochemical Outcomes With Statin Use in Patients With High-Risk Localized Prostate Cancer Treated With RadiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Association of statin and nonsteroidal anti‐inflammatory drug use with prostate cancer outcomes: results from CaPSUREBJU International, 2010
- Statin medication use and the risk of biochemical recurrence after radical prostatectomyCancer, 2010
- Statin Use and Risk of Prostate Cancer Recurrence in Men Treated With Radiation TherapyJournal of Clinical Oncology, 2010
- No Effect of Statins on Biochemical Outcomes After Radiotherapy for Localized Prostate CancerUrology, 2009
- Statin Drugs and Risk of Advanced Prostate CancerJNCI Journal of the National Cancer Institute, 2006
- Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancerUrology, 2005
- Cholesterol Lowering in the Management of Coronary Artery Disease: The Clinical Implications of Recent TrialsAmerican Journal Of Medicine, 1998